Table 2. Multivariate analysis of prognostic factors in the 291 patients with locally recurrent NPC receiving salvage IMRT.
Endpoint | Variable | HR | 95% CI | P value |
---|---|---|---|---|
LFFS | Recurrent T classification* (rT3-4vs. r1-2) | 3.837 | 1.543–9.542 | 0.004 |
DMFS | TV | 1.013 | 1.004–1.022 | 0.003 |
OS | TV | 1.015 | 1.011–1.020 | <0.001 |
Age | 1.025 | 1.012–1.038 | <0.001 | |
Recurrent T classification* (rT3-4vs. r1-2) | 1.916 | 1.206–3.042 | 0.006 | |
Recurrence interval | 0.994 | 0.990–0.998 | 0.003 | |
TRD | TV | 1.014 | 1.007–1.021 | <0.001 |
Age | 1.026 | 1.007–1.045 | 0.006 | |
Recurrence interval | 0.994 | 0.989–1.000 | 0.048 |
Abbreviations: TV, gross recurrent tumor volume; HR, hazard ratio; CI, confidence interval; LFFS, local failure-free survival; DMFS, distant metastasis-free survival; OS, overall survival; TRD, toxicity-related death.
* According to the 7th AJCC/UICC staging system. The following parameters were included in the Cox proportional hazards model by backward elimination: recurrence interval as a continuous variable, age as a continuous variable, gender (female vs. male), World Health Organization (WHO) histological grade (Type II vs. Type I), recurrent T classification (rT3-4 vs. rT1-2), recurrent N classification (rN1-3 vs. rN0), initial radiotherapy dose (>70Gy vs. ≤ 70Gy), use of chemotherapy (with vs. without) and TV as a continuous variable.